A Johnson & Johnson subsidiary and a California investment firm have agreed to an $11.5 million settlement resolving whistleblower claims over a cancer treatment system that was allegedly marketed off label to children.

The U.S. Attorney’s Office for the Eastern District of Pennsylvania, which announced the settlement, said J&J subsidiary Medical Device Business Services Inc. will provide $10 million toward the settlement, while The Gores Group, an investment firm based in Los Angeles, will pay $1.5 million.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]